The Oncology Institute, Inc. TOI FFS revenue — Total operating revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s ffs revenue — total operating revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s FFS revenue — total operating revenue?
- The Oncology Institute, Inc. (TOI) reported FFS revenue — total operating revenue of $32.16M in Q1 2026.
- How has The Oncology Institute, Inc.'s FFS revenue — total operating revenue changed year-over-year?
- The Oncology Institute, Inc.'s FFS revenue — total operating revenue decreased by 9.6% year-over-year, from $35.57M to $32.16M.
- What is the long-term trend for The Oncology Institute, Inc.'s FFS revenue — total operating revenue?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s FFS revenue — total operating revenue has grown at a 20.8% compound annual growth rate (CAGR), from $69.79M to $148.51M.
- What does FFS revenue — total operating revenue mean?
- This metric represents the total gross revenue generated specifically from fee-for-service (FFS) oncology patient care activities. It captures the financial performance of clinical services where providers are compensated based on the volume and type of individual medical procedures and treatments performed. This segment is a primary indicator of the company's core operational scale and patient service delivery capacity within the oncology market.